Press

 

Media presence is a key part of making society aware of developments in biotechnology and its benefits.This is where we post all our press releases. If you are a journalist interested in learning more about the biotechnology sector, contact Agathe Cortes, our Head of Communicationacortes@asebio.com

Search engine
cristobal belda
Genomics is positioning itself as a key tool for cancer diagnosis and treatment
Healthcare · Personalized medicine
  • AseBio and Illumina have brought together legislators, clinicians, researchers and biotech companies at the Instituto de Salud Carlos III to promote personalised and precision medicine in oncology.
  • Cancer has been the main research area among AseBio members for more than 15 years, with almost 350 open lines of treatment and diagnosis.
AseBio
biovegen
AseBio y Biovegen se unen para impulsar un cambio de legislación de las nuevas técnicas genómicas
Agrifood
  • Las dos principales asociaciones del sector biotecnológico agroalimentario español invitan a las empresas a participar en la consulta pública de la Comisión Europea
AseBio
Ana Polanco
Spanish biotechnology sector breaks record figures for six years in a row, according to AseBio 2021 Report
  • The economic impact of the sector is growing, accounting for 0.9% of national GDP.
  • The industry attracts 180 million euros of private investment, 20% more than in 2020.
  • Productivity per employee is three times the national average and wages per employee almost double
  • Biotechnology is the industry with the highest intensity of investment in R&D and in the hiring of researchers.
  • Biotech companies increase their scientific production by 50%. 
AseBio
pacto climatico
AseBio and MNCN-CSIC bring together nearly 1,000 people to raise awareness of role science plays in protecting the planet
Climate change · Agrifood · Industrial biotechnology
  • This 2022 Environment Week also falls under the framework of the European Climate Pact, for which AseBio is the national coordinator and has over 130 ambassadors
  • Over 100 biotechnology companies are looking for solutions to help the environment, such as cutting CO2 emissions, water treatment and improved crops
AseBio
foto agro
Biotechnology positioned as a strategic tool to promote sustainable agrifood
Agrifood
  • AseBio partners develop almost 200 products to improve the agrifood system and protect the planet in a context of great challenges.
  • In 2021, Spanish biotechnology companies attracted 14% of the private capital raised by the entire sector 
AseBio
biospain
Barcelona to host BIOSPAIN 2023 international conference on biotechnology
International
  • AseBio, in collaboration with Biocat, the Government of Catalonia and Barcelona City Council, will hold one of the most important international biotechnology meetings in southern Europe at the Fira de Barcelona.
  • The event is expected to bring together more than 1,500 professionals from over 850 organisations from more than 30 countries working in health, sustainable agri-food and climate change solutions in September 2023.
  • The BioRegion of Catalonia leads the Spanish biotech ecosystem in terms of number of biotech companies, turnover and attracting international investment.
AseBio
equipo rpemiados
Sanifit, Ysios Capital, Splice Bio and MOA foodtech recognised at first AseBio – PwC Awards
Talento · Corporate
  • The ceremony to award these 6 prizes to Spanish biotechnology took place at AseBio Investor Day 2022, which brought together over 260 participants from all over Europe
  • Sanifit has received three awards, positioning itself as the biotech company of the year 2021
AseBio
Ion Arocena
Spanish biotechnology hits new record, attracting over €180 million in private investment in 2021
International · Financing
  • Private investment in the biotech industry up 20% from 2020.
  • The figures were announced at AseBio Investor Day 2022, which brought together over 50 investors from all over Europe and more than 260 participants

AseBio
coronavirus
Two years of the pandemic: Nearly 30% of new research into Covid-19 by our members is carving a path to the public
Coronavirus
  • Over 53 biotech organisations are working on 170 solutions to the pandemic and 27% of them have already reached the market
  • Almost half of the lines of research are aimed at diagnosing the disease
AseBio